Glenmark Pharmaceuticals Europe Ltd.

Glenmark is a leading player in the discovery of new molecules, both NCEs (new chemical entity) and NBEs (new biological entity), with seven molecules in various stages of clinical development & pre-clinical development. The company has a significant presence in branded generics markets across emerging economies including India. It's subsidiary, Glenmark Generics Limited has a fast growing and robust US generics business. The subsidiary also markets APIs to regulated and semi-regulated countries. Glenmark employs over 10,400 people in over 80 countries. It has thirteen manufacturing facilities in four countries and has five R&D centres.


Contact details

Building 2, 1st Floor, Croxley Green Business Park
Marlins Meadow
WD18 8YA
United Kingdom